2021
DOI: 10.1590/1806-9282.67.suppl1.20200703
|View full text |Cite
|
Sign up to set email alerts
|

Association of ABO blood group and age with COVID-19 positive test

Abstract: The aim of this study is to evaluate the relation between the coronavirus (SARS-CoV-2) disease and blood groups and the Rh factor. METHOD: A total of 313 patients hospitalized in the Internal Medicine clinic, at the intensive care unit (ICU) were included in the study. The cases were divided into two groups: those who were COVID-19 positive and those negative, detected with real-time reverse transcription polymerase chain reaction testing. The demographic, clinical, ABO blood groups, and Rh factor data of the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
0
1

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(13 citation statements)
references
References 16 publications
(25 reference statements)
0
8
0
1
Order By: Relevance
“…The sample size of n=56 in [6] might be too small. In [40] , O frequency is higher in COVID-19 positive group than negative group. Our recalculation by Fisher’s test on the data in [40] , however, showed an insignificant conclusion (p-value=0.11).…”
Section: Discussionmentioning
confidence: 80%
See 2 more Smart Citations
“…The sample size of n=56 in [6] might be too small. In [40] , O frequency is higher in COVID-19 positive group than negative group. Our recalculation by Fisher’s test on the data in [40] , however, showed an insignificant conclusion (p-value=0.11).…”
Section: Discussionmentioning
confidence: 80%
“…In [40] , O frequency is higher in COVID-19 positive group than negative group. Our recalculation by Fisher’s test on the data in [40] , however, showed an insignificant conclusion (p-value=0.11). In [15] , O frequency was higher in PCR-positive than PCR-negative (but still had symptom).…”
Section: Discussionmentioning
confidence: 80%
See 1 more Smart Citation
“… NALBANT et al ., 2022, Turkey. ( 19 ) Cohort / 9 313 - 220 cases* - 93 controls 2 COVID-19 infection - No significant difference AMOROSO et al ., 2021, Italy. ( 20 ) Cohort / 8 40,904 - 219 cases** - 40,685 controls 2 COVID-19 infection - Group A was more prevalent in COVID patients compared to controls MUÑOZ-CULLA et al ., 2021, Basque.…”
Section: Methodsmentioning
confidence: 99%
“…(2021) ( 18 ) Cohort **** ** *** NALBANT et al . (2022) ( 19 ) Cohort **** ** *** AMOROSO et al . (2021) ( 20 ) Cohort **** * *** SZYMANSKI et al .…”
Section: Methodsmentioning
confidence: 99%